Figure 6.
Functional analyses of the high- and low-risk groups. (A) Differences in biological functions by GSEA analysis. (B) Heatmap of the 22 immune cell types in high- and low-risk groups. (C) The fractions of 22 immune cell types estimated with CIBERSORT and the differences between low- and high-risk LUAD patients. (D) Differential expression analysis of immune checkpoint genes. *p < 0.05; **p < 0.01; ***p < 0.001.